pharmaphorum12h
The future of multiple myeloma is personalised, but we must work together to deliver it
The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...
STAT15h
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
Managed Healthcare Executive1d
Quantitative Studies Next Step to Understand Clinical Meaningfulness in Metastatic Breast Cancer Care
More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...
Cochrane1d
Cochrane helps launch new WHO guidance on best practices for clinical trials
Eva Madrid, the Lead of Cochrane’s new Iberoamérica Evidence Synthesis Unit, spoke on the panel of the launch event for the ...
sir.advancedleadership.harvard1d
Unlocking the Health and Economic Returns of Closing the Women's Health Gap
Women often do not receive gender-specific health care, leading to disparities in treatment and outcomes. Megan Greenfield ...
BioPharma Dive2d
An effective analytical testing strategy for viral vectors should include these 7 steps
Producing safe, effective, high-quality viral vector therapeutics depends on a robust and tailored analytical testing strategy.
devdiscourse6d
Rwanda Stepping Up Against Marburg: Clinical Trials on the Horizon
Rwanda is set to launch clinical trials for vaccines and therapeutics targeting Marburg viral disease. Confirmed in late September, the disease has claimed 11 lives and 36 cases have been reported.